MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 185 filers reported holding MIRATI THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,421,577 | -19.2% | 38,235 | -1.6% | 0.01% | -18.8% |
| Q4 2022 | $1,759,840 | -17.1% | 38,840 | +27.9% | 0.02% | -20.0% |
| Q3 2022 | $2,122,000 | -4.0% | 30,379 | -7.8% | 0.02% | -4.8% |
| Q2 2022 | $2,211,000 | -76.6% | 32,935 | -42.1% | 0.02% | -84.9% |
| Q3 2020 | $9,438,000 | +38.9% | 56,836 | -4.5% | 0.14% | +52.7% |
| Q2 2020 | $6,797,000 | +14.8% | 59,530 | -22.7% | 0.09% | -1.1% |
| Q1 2020 | $5,919,000 | -42.2% | 77,000 | -3.1% | 0.09% | +15.0% |
| Q4 2019 | $10,239,000 | +67.7% | 79,456 | +1.4% | 0.08% | +66.7% |
| Q3 2019 | $6,107,000 | -21.2% | 78,380 | +4.2% | 0.05% | -15.8% |
| Q2 2019 | $7,746,000 | +28.2% | 75,203 | -8.8% | 0.06% | +32.6% |
| Q1 2019 | $6,042,000 | +89.5% | 82,434 | +9.7% | 0.04% | +72.0% |
| Q4 2018 | $3,188,000 | +18.2% | 75,144 | +31.2% | 0.02% | +38.9% |
| Q3 2018 | $2,697,000 | +29.8% | 57,263 | +35.8% | 0.02% | +28.6% |
| Q2 2018 | $2,078,000 | – | 42,159 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |